Medicine and Dentistry
Patient
100%
COVID-19
72%
Randomized Clinical Trial
28%
Mortality
21%
Therapeutic Procedure
20%
Hazard Ratio
17%
Odds Ratio
17%
Intensive Care Unit
17%
Association
16%
Organ
15%
Survival
14%
Intensive Care
14%
Obstetric Delivery
14%
Perioperative Period
14%
Ascorbic Acid
14%
Simvastatin
14%
Prevalence
14%
Frailty
14%
Cohort Analysis
14%
Quality Improvement
14%
Clinical Research
14%
Sepsis
14%
Home Rehabilitation
14%
Medical Science
14%
Age
12%
Case Mix
11%
Hospital
10%
Physiotherapy
9%
Tracheostomy
9%
Death
8%
Cohort Effect
8%
Analysis
8%
Morbidity
7%
Health System
7%
Hospital Mortality
6%
Clinical Trial
5%
Medical Specialty
5%
Adoption
5%
Pharmacology, Toxicology and Pharmaceutical Science
Survival
20%
Infection
16%
Angiotensin Receptor Antagonist
14%
Dipeptidyl Carboxypeptidase Inhibitor
14%
Randomized Clinical Trial
14%
Ascorbic Acid
14%
Coronavirinae
14%
Simvastatin
14%
Diseases
14%
Death
9%
Mortality
5%
Nursing and Health Professions
Ascorbic Acid
14%
Home Rehabilitation
14%
Peer Review
14%
Tracheostomy
9%
Physiotherapy
9%
Control
7%
Odds Ratio
7%
Death
7%
Survival
5%